LAGUNA HILLS, Calif., Sept. 4, 2019 /PRNewswire/ – Sonendo®, Inc., the developer of the GentleWave® System, a breakthrough technology for the dental marketplace, today announced that President and CEO, Bjarne Bergheim, will present at the Baird 2019 Global Healthcare Conference on Thursday, Sept 5, 2019, 11:25 a.m. EDT. The conference will take place in New York, NY.
About the event, Bjarne Bergheim stated, "2019 is proving to be another exciting year for Sonendo. I look forward to attending this year's conference and sharing our accomplishments over the last twelve months."
Sonendo, Inc. is a privately-held company developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO™ Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05. 3Trope M et al. (1999) J Endod. 25:345–50.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments, or events could differ materially from those disclosed in the forward-looking statements.